Risk

American Journal of Epidemiology

Volumn 181, Issue 4, 2015, Pages 246-250

  Cole, Stephen R ^a   Hudgens, Michael G ^a   Brookhart, M Alan ^a   Westreich, Daniel ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Causal inference; Cohort study; Semi Bayes method; Semiparametric inference; Survival analysis

Indexed keywords

COHORT ANALYSIS; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS; NUMERICAL METHOD; RISK ASSESSMENT; SURVIVAL; SURVIVORSHIP;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ATTRIBUTABLE RISK; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; OVERALL SURVIVAL; RISK; STATISTICAL ANALYSIS; COHORT ANALYSIS; EPIDEMIOLOGY; HIV INFECTIONS; INCIDENCE; MATHEMATICAL COMPUTING; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; COHORT STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MATHEMATICAL COMPUTING; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84941696094     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv001     Document Type: Article

References (57)

1. Westreich D, Pence BW, Turner AN. In populo. Epidemiology. 2010;21(1):152-153.
2. Rothman KJ, Greenland S, Lash T. Modern Epidemiology. 3rd ed. New York, NY: Lippincott-Raven; 2008.
3. Westreich D, Cole SR, Young JG, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med. 2012;31(18): 2000-2009.
4. Cole SR, Lau B, Eron JJ, et al. Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol. 2015; 181(4):238-245.
5. Robins JM. Confidence intervals for causal parameters. Stat Med. 1988;7(7):773-785.
6. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist. 1988;16(3):1141-1154.
7. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244-256.
8. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11): 2389-2430.
9. Andersen PK, Geskus RB, deWitte T, et al. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012; 41(3):861-870.
10. Greenland S. Epidemiologic measures and policy formulation: lessons from potential outcomes. Emerg Themes Epidemiol. 2005;2:5.
11. Robins JM, Greenland S. Comment on: causal inference without counterfactuals. J Am Stat Assoc. 2000;95(450):431-435.
12. Lindley DV. Understanding Uncertainty. New York, NY: John Wiley & Sons; 2007.
13. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560.
14. Cole SR, Richardson DB, Chu H, et al. Analysis of occupational asbestos exposure and lung cancer mortality using the g formula. Am J Epidemiol. 2013;177(9):989-996.
15. Samet JM, Muñoz A. Evolution of the cohort study. Epidemiol Rev. 1998;20(1):1-14.
16. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6): 656-664.
17. Hudgens MG, Halloran ME. Toward causal inference with interference. J Am Stat Assoc. 2008;103(482):832-842.
18. Rubin DB. Discussion of "Randomized analysis of experimental data: the Fisher randomization test" by Basu D. J Am Stat Assoc. 1980;75(371):591-593.
19. VanderWeele TJ. Concerning the consistency assumption in causal inference. Epidemiology. 2009;20(6):880-883.
20. Hernán MA, Cole SR. Invited commentary: causal diagrams and measurement bias. Am J Epidemiol. 2009;170(8):959-962.
21. Robins JM. The analysis of randomized and nonrandomized AIDS treatment trials using a new approach to causal inference in longitudinal studies. In: Sechrest L, Freeman H, Mulley A, eds. Health Service Research Methodology: A Focus on AIDS. Washington, DC: US Public Health Service; 1989: 113-159.
22. Manski CF. Nonparametric bounds on treatment effects. Am Econ Rev. 1990;80(2):319-323.
23. Balke A, Pearl J. Bounds on treatment effects from studies with imperfect compliance. J Am Stat Assoc. 1997;92(439): 1171-1176.
24. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol. 1996;25(6):1107-1116.
25. Lash TL, Fink AK. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology. 2003;14(4):451-458.
26. Brumback BA, Hernán MA, Haneuse SJ, et al. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Stat Med. 2004;23(5): 749-767.
27. Steenland K, Greenland S. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol. 2004;160(4): 384-392.
28. Greenland S. Multiple-bias modelling for analysis of observational data. J R Stat Soc Ser A Stat Soc. 2005; 168(part 2):267-306.
29. Aalen OO, Johansen S. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978;5(3):141-150.
30. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000;56(3):779-788.
31. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004; 75(1):45-49.
32. Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc Series B. 1976;38(3):290-295.
33. Geskus RB. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011;67(1):39-49.
34. Newey WK. Semiparametric efficiency bounds. J Appl Econ. 1990;5(2):99-135.
35. Robins JM, Rotnitzky A, Zhao LP. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc. 1994;89(427):846-846.
36. Tsiatis AA. Semiparametric Theory and Missing Data. New York, NY: Springer; 2006.
37. Van der Laan M, Rose S. Targeted Learning: Causal Inference From Observational and Experimental Data. New York, NY: Springer; 2011.
38. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
39. Greenland S, O'Rourke K. Meta-analysis. In: Rothman KJ, Greenland S, Lash T, eds. Modern Epidemiology. 3rd ed. Philadelphia, PA: LippincottWilliams & Wilkins; 2008:652-682.
40. Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol. 1999;150(5):469-475.
41. Greenland S. Generalized conjugate priors for Bayesian analysis of risk and survival regressions. Biometrics. 2003; 59(1):92-99.
42. Good IJ. The Bayes/non-Bayes compromise: a brief review. J Am Stat Assoc. 1992;87(419):597-606.
43. Greenland S. Bayesian perspectives for epidemiological research: I. Foundations and basic methods. Int J Epidemiol. 2006;35(3):765-775.
44. Cole SR, Chu H, Greenland S. Maximum likelihood, profile likelihood, and penalized likelihood: a primer. Am J Epidemiol. 2014;179(2):252-260.
45. Hernán MA, VanderWeele TJ. Compound treatments and transportability of causal inference. Epidemiology. 2011;22(3): 368-377.
46. Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial. Am J Epidemiol. 2010;172(1):107-115.
47. Hoggatt KJ, Greenland S. Commentary: extending organizational schema for causal effects. Epidemiology. 2014; 25(1):98-102.
48. Hernán MA, Cole SR, Robins J. Estimating short-term effects of time-varying exposures on survival. Am J Epidemiol. 2001; 153(11 Suppl):S257-S960.
49. Hernán MA. The hazards of hazard ratios. Epidemiology. 2010; 21(1):13-15.
50. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology. 1996;7(5):498-501.
51. Greenland S. Confounding of incidence density ratio in case-control studies. Epidemiology. 2013;24(4):624-625.
52. Kraemer HC. Events per person-time (incidence rate): a misleading statistic? Stat Med. 2009;28(6):1028-1039.
53. Robins J. A new approach to causal inference in mortality studies with a sustained exposure period: application to control of the healthy worker survivor effect. Math Model. 1986; 7(9-12):1393-1512.
54. Robins JM, Hernán MA. Estimation of the causal effects of time-varying exposures. In: Fitzmaurice G, Davidian M, Verbeke G, et al, eds. Longitudinal Data Analysis. New York, NY: Chapman and Hall; 2008:553-597.
55. Cole SR, Chu H. Effect of acyclovir on herpetic ocular recurrence using a structural nested model. Contemp Clin Trials. 2005;26(3):300-310.
56. Cole SR, Hernán MA, Robins JM, et al. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003;158(7):687-694.
57. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics. 1990;46(3):813-826.